SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-18-000110
Filing Date
2018-11-08
Accepted
2018-11-08 17:02:45
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx10-q2018x09.htm 10-Q 922226
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit311.htm EX-31.1 9840
3 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit321.htm EX-32.1 6699
  Complete submission text file 0001610618-18-000110.txt   4439876

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cdtx-20180930.xml EX-101.INS 753747
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20180930.xsd EX-101.SCH 36608
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20180930_cal.xml EX-101.CAL 53169
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20180930_def.xml EX-101.DEF 185682
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20180930_lab.xml EX-101.LAB 535159
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20180930_pre.xml EX-101.PRE 299659
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 181170478
SIC: 2836 Biological Products, (No Diagnostic Substances)